Getinge AB (publ) (GNGBF)
USD 15.68
(0.0%)
USD 15.68
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 23.18 Billion SEK | 7.43% |
| 2022 | 21.57 Billion SEK | 11.35% |
| 2021 | 19.37 Billion SEK | -17.63% |
| 2020 | 23.52 Billion SEK | -0.89% |
| 2019 | 23.74 Billion SEK | 0.18% |
| 2018 | 23.69 Billion SEK | 6.28% |
| 2017 | 22.29 Billion SEK | -34.99% |
| 2016 | 34.29 Billion SEK | 1.94% |
| 2015 | 33.64 Billion SEK | -1.41% |
| 2014 | 34.12 Billion SEK | 23.0% |
| 2013 | 27.74 Billion SEK | 0.08% |
| 2012 | 27.72 Billion SEK | 3.31% |
| 2011 | 26.83 Billion SEK | 25.76% |
| 2010 | 21.33 Billion SEK | -14.43% |
| 2009 | 24.93 Billion SEK | 11.54% |
| 2008 | 22.35 Billion SEK | 36.58% |
| 2007 | 16.36 Billion SEK | 65.8% |
| 2006 | 9.87 Billion SEK | 7.87% |
| 2005 | 9.15 Billion SEK | 11.78% |
| 2004 | 8.18 Billion SEK | -3.69% |
| 2003 | 8.5 Billion SEK | 34.53% |
| 2002 | 6.31 Billion SEK | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 23.52 Billion SEK | -0.8% |
| 2024 Q3 | 29.14 Billion SEK | 23.89% |
| 2024 Q1 | 23.71 Billion SEK | 2.31% |
| 2023 Q4 | 23.18 Billion SEK | 7.7% |
| 2023 Q1 | 19.92 Billion SEK | -7.66% |
| 2023 Q2 | 21.53 Billion SEK | 8.08% |
| 2023 Q3 | 21.52 Billion SEK | -0.06% |
| 2023 FY | 23.18 Billion SEK | 7.43% |
| 2022 Q4 | 21.57 Billion SEK | 2.76% |
| 2022 Q2 | 20.2 Billion SEK | 6.76% |
| 2022 Q1 | 18.92 Billion SEK | -2.33% |
| 2022 Q3 | 21 Billion SEK | 3.92% |
| 2022 FY | 21.57 Billion SEK | 11.35% |
| 2021 Q2 | 18.89 Billion SEK | -12.72% |
| 2021 FY | 19.37 Billion SEK | -17.63% |
| 2021 Q4 | 19.37 Billion SEK | 0.02% |
| 2021 Q3 | 19.37 Billion SEK | 2.56% |
| 2021 Q1 | 21.64 Billion SEK | -8.01% |
| 2020 Q4 | 23.52 Billion SEK | -10.29% |
| 2020 FY | 23.52 Billion SEK | -0.89% |
| 2020 Q1 | 25.51 Billion SEK | 7.49% |
| 2020 Q2 | 28.06 Billion SEK | 9.98% |
| 2020 Q3 | 26.22 Billion SEK | -6.55% |
| 2019 Q3 | 25.7 Billion SEK | 2.56% |
| 2019 Q2 | 25.06 Billion SEK | 1.91% |
| 2019 FY | 23.74 Billion SEK | 0.18% |
| 2019 Q1 | 24.59 Billion SEK | 3.77% |
| 2019 Q4 | 23.74 Billion SEK | -7.63% |
| 2018 Q2 | 22.79 Billion SEK | 3.66% |
| 2018 Q4 | 23.69 Billion SEK | -0.09% |
| 2018 FY | 23.69 Billion SEK | 6.28% |
| 2018 Q3 | 23.71 Billion SEK | 4.04% |
| 2018 Q1 | 21.99 Billion SEK | -1.37% |
| 2017 FY | 22.29 Billion SEK | -34.99% |
| 2017 Q1 | 34.17 Billion SEK | -0.34% |
| 2017 Q3 | 27.9 Billion SEK | -14.88% |
| 2017 Q2 | 32.77 Billion SEK | -4.1% |
| 2017 Q4 | 22.29 Billion SEK | -20.09% |
| 2016 Q4 | 34.29 Billion SEK | -2.01% |
| 2016 FY | 34.29 Billion SEK | 1.94% |
| 2016 Q3 | 34.99 Billion SEK | 1.21% |
| 2016 Q2 | 34.57 Billion SEK | 3.92% |
| 2016 Q1 | 33.27 Billion SEK | -1.09% |
| 2015 Q4 | 33.64 Billion SEK | -3.05% |
| 2015 FY | 33.64 Billion SEK | -1.41% |
| 2015 Q3 | 34.7 Billion SEK | 0.28% |
| 2015 Q2 | 34.6 Billion SEK | -6.42% |
| 2015 Q1 | 36.98 Billion SEK | 8.37% |
| 2014 Q2 | 30.66 Billion SEK | 2.46% |
| 2014 Q3 | 31.9 Billion SEK | 4.06% |
| 2014 Q4 | 34.12 Billion SEK | 6.95% |
| 2014 Q1 | 29.92 Billion SEK | 7.87% |
| 2014 FY | 34.12 Billion SEK | 23.0% |
| 2013 Q2 | 29.18 Billion SEK | 4.94% |
| 2013 Q1 | 27.8 Billion SEK | 0.32% |
| 2013 Q4 | 27.74 Billion SEK | -0.54% |
| 2013 FY | 27.74 Billion SEK | 0.08% |
| 2013 Q3 | 27.89 Billion SEK | -4.42% |
| 2012 Q2 | 26.54 Billion SEK | 6.25% |
| 2012 Q4 | 27.72 Billion SEK | 6.37% |
| 2012 FY | 27.72 Billion SEK | 3.31% |
| 2012 Q1 | 24.98 Billion SEK | -6.91% |
| 2012 Q3 | 26.06 Billion SEK | -1.8% |
| 2011 FY | 26.83 Billion SEK | 25.76% |
| 2011 Q4 | 26.83 Billion SEK | 25.81% |
| 2011 Q3 | 21.32 Billion SEK | 4.12% |
| 2011 Q2 | 20.48 Billion SEK | 2.26% |
| 2011 Q1 | 20.03 Billion SEK | -6.11% |
| 2010 Q1 | 23.7 Billion SEK | -4.95% |
| 2010 Q2 | 24.74 Billion SEK | 4.41% |
| 2010 Q4 | 21.33 Billion SEK | -3.66% |
| 2010 Q3 | 22.14 Billion SEK | -10.5% |
| 2010 FY | 21.33 Billion SEK | -14.43% |
| 2009 Q4 | 24.93 Billion SEK | 0.0% |
| 2009 FY | 24.93 Billion SEK | 11.54% |
| 2008 FY | 22.35 Billion SEK | 36.58% |
| 2007 FY | 16.36 Billion SEK | 65.8% |
| 2006 FY | 9.87 Billion SEK | 7.87% |
| 2005 FY | 9.15 Billion SEK | 11.78% |
| 2004 FY | 8.18 Billion SEK | -3.69% |
| 2003 FY | 8.5 Billion SEK | 34.53% |
| 2002 FY | 6.31 Billion SEK | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AVITA Medical, Inc. | 19.86 Million USD | -116595.342% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | -1094423.135% |
| Össur hf. | 688.8 Million USD | -3265.534% |
| QHSLab, Inc. | 2.05 Million USD | -1126854.195% |
| Wellstar International, Inc. | 55.99 Million USD | -41303.418% |
| Össur hf. | 688.8 Million USD | -3265.534% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 2.94 Million USD | -786172.154% |
| Aurora Spine Corporation | 6.65 Million USD | -348316.241% |
| BrainsWay Ltd. | 15.31 Million USD | -151277.824% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 16.62 Million USD | -139358.998% |
| Hamilton Thorne Ltd. | 45.84 Million USD | -50468.435% |
| Vivos Inc. | 245 Thousand USD | -9461786.337% |
| Kelyniam Global, Inc. | 1.01 Million USD | -2288496.998% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -8410938.626% |
| Zecotek Photonics Inc. | 5.86 Million USD | -394917.147% |
| Avitar, Inc. | 11.59 Million USD | -199856.251% |
| Nanomix Corporation | 14.81 Million USD | -156379.216% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | -144061.87% |
| Theraclion SA | 13.01 Million EUR | -177996.087% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 2.02 Million USD | -1144126.204% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | -640079.831% |
| Lombard Medical, Inc. | 53.79 Million USD | -42994.025% |
| ALR Technologies Inc. | 24.5 Million USD | -94499.712% |
| Stratec SE | 271.97 Million USD | -8423.723% |
| Vycor Medical, Inc. | 4.31 Million USD | -536797.021% |
| Heart Tronics, Inc. | 1.09 Million USD | -2117385.652% |
| MicroPort Scientific Corporation | 2.48 Billion USD | -832.356% |
| VMS Rehab Systems, Inc. | 201.36 USD | -11512713447.874% |
| NewCardio, Inc. | 6.01 Million USD | -385453.983% |
| Guided Therapeutics, Inc. | 5.47 Million USD | -423315.525% |
| Ingen Technologies, Inc. | 5.7 Million USD | -405921.704% |
| Odyssey Group International, Inc. | 6.61 Million USD | -350519.702% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | -946178.239% |
| Wellness Center USA, Inc. | 5.12 Million USD | -452302.591% |
| SANUWAVE Health, Inc. | 65.59 Million USD | -35241.648% |
| IR-Med Inc. | 634 Thousand USD | -3656366.877% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | -423194.451% |
| Polarean Imaging plc | 2.58 Million USD | -898239.455% |
| United American Healthcare Corporation | 119 Thousand USD | -19480572.269% |
| ECGI Holdings, Inc. | 11.94 Million USD | -194048.234% |
| Nu-Med Plus, Inc. | 2.35 Million USD | -982693.691% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -1750827.504% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -1602707.644% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -3421011.662% |
| Urologix, Inc. | 12.64 Million USD | -183243.879% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | -429509.513% |
| Nexeon MedSystems Inc. | 8.48 Million USD | -273193.522% |
| SS Innovations International, Inc. | 11.18 Million USD | -207231.979% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -4412266.503% |
| Smith & Nephew plc | 4.76 Billion USD | -386.683% |
| NIOX Group Plc | 9.8 Million USD | -236400.342% |
| Fuse Medical, Inc. | 15.11 Million USD | -153320.915% |
| Broncus Holding Corporation | 10.43 Million USD | -222116.513% |
| Brain Scientific Inc. | 7.42 Million USD | -312056.504% |
| Pressure BioSciences, Inc. | 33.8 Million USD | -68478.687% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -2919249.537% |